HealthArticle 5 of 18

India validates its first indigenous HPV test for cervical cancer screening

Friday, 12 June 2026· 5 min read·Source: Express Healthcare

India has validated its first indigenous HPV (Human Papillomavirus) test for cervical cancer screening that meets international standards, a milestone in affordable women's healthcare reported around June 10-12, 2026. Of four home-grown HPV DNA tests evaluated, Truenat HR-HPV-Plus, developed by Goa-based Molbio Diagnostics, was the only assay to fully satisfy international validation criteria. The validation involved AIIMS, ICMR and IARC. The World Health Organization recommends HPV DNA testing as the preferred cervical-cancer screening method due to its higher sensitivity than conventional Pap-smear cytology. An affordable indigenous test could widen screening access, especially in rural areas, in a country where cervical cancer kills an estimated 80,000 women a year.

Key Facts & Details

8 points

1
India validated its first indigenous HPV test for cervical cancer screening.
2
The test, Truenat HR-HPV-Plus, was developed by Goa-based Molbio Diagnostics.
3
It was the only one of four indigenous assays to fully meet international validation criteria.
4
Validation involved AIIMS, ICMR and IARC.
5
WHO recommends HPV DNA testing as the preferred cervical-cancer screening method.

Deep Dive

+
An affordable home-grown test can expand screening in rural and underserved areas.
+
Cervical cancer is among the leading cancers affecting Indian women, killing about 80,000 annually.
+
HPV DNA tests detect high-risk HPV infections that can lead to cervical cancer.

Exam Focus

India's first validated indigenous HPV test for cervical cancer screening was developed by which company?

Exam Relevance & Angle

Indigenous health-technology breakthroughs are science/health GA; exams test the test name, the developer, the disease targeted and the global standard-setter (WHO).

Target Exams

SBI POSBI ClerkIBPS POIBPS ClerkIBPS RRB OfficerIBPS RRB AssistantRBI Grade BNABARD Grade ASSC CGLSSC CHSLSSC CPORRB NTPCLIC AAOUPSC CSEState PCS

Background & Context

Human Papillomavirus (HPV) is a common sexually transmitted virus; persistent infection with high-risk HPV types is the main cause of cervical cancer, one of the most common cancers among women. Screening detects pre-cancerous changes early. The World Health Organization (WHO) recommends HPV DNA testing over older Pap-smear cytology because of its higher sensitivity, as part of its goal to eliminate cervical cancer. Key Indian institutions in such validation include the All India Institute of Medical Sciences (AIIMS), the Indian Council of Medical Research (ICMR) and the WHO's International Agency for Research on Cancer (IARC). Indigenous, low-cost diagnostics support the 'Make in India' health push.